<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>anesthetic &#8211; UF Innovate</title>
	<atom:link href="https://innovate.research.ufl.edu/tag/anesthetic/feed/" rel="self" type="application/rss+xml" />
	<link>https://innovate.research.ufl.edu</link>
	<description>Building business on innovation</description>
	<lastBuildDate>Tue, 12 Aug 2025 04:48:33 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://innovate.research.ufl.edu/wp-content/uploads/favicon-blue_1.png</url>
	<title>anesthetic &#8211; UF Innovate</title>
	<link>https://innovate.research.ufl.edu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>‘Lifesaving’ Ketamine Offers New Hope for PTSD Sufferers</title>
		<link>https://innovate.research.ufl.edu/new-hope-for-ptsd-sufferers/</link>
		
		<dc:creator><![CDATA[sooyoungryu]]></dc:creator>
		<pubDate>Thu, 31 Jul 2025 00:00:00 +0000</pubDate>
				<category><![CDATA[News Brief]]></category>
		<category><![CDATA[anesthetic]]></category>
		<category><![CDATA[European Journal of Trauma & Dissociation.]]></category>
		<category><![CDATA[ketamine]]></category>
		<category><![CDATA[mental health]]></category>
		<category><![CDATA[Meredith Berry]]></category>
		<category><![CDATA[post-traumatic stress disorder]]></category>
		<category><![CDATA[PTSD]]></category>
		<category><![CDATA[Shahar Almog]]></category>
		<category><![CDATA[UF College of Health and Human Performance]]></category>
		<guid isPermaLink="false">https://scaddev1.com/new-hope-for-ptsd-sufferers/</guid>

					<description><![CDATA[A UF study led by 2024 graduate Shahar Almog, Ph.D., reveals additional mental health benefits of ketamine, further supporting its potential as a treatment for depression and PTSD.]]></description>
										<content:encoded><![CDATA[
<p>A growing number of Americans are turning to ketamine — long used as a surgical anesthetic and known for recreational misuse — as a powerful treatment for depression and post-traumatic stress disorder, or PTSD. A University of Florida study, led by 2024 graduate Shahar Almog, Ph.D., suggests that the drug may offer even more mental health benefits than previously thought. </p>



<p>When used under medical supervision, ketamine may help people with PTSD disconnect from their emotions and better process traumatic experiences. About 6 to 7% of U.S. adults will develop PTSD in their lifetimes, often alongside depression and anxiety, according to the National Institute of Mental Health.&nbsp;</p>



Read more about <a href="https://news.ufl.edu/2025/07/new-hope-for-ptsd-sufferers/"> ‘Lifesaving’ Ketamine Offers New Hope for PTSD Sufferers.</a>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
